What amount sold does Sentire Medical Systems, Inc. report in Form D filings?

The latest linked filings report $1.8M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Sentire Medical Systems, Inc.'s most recent SEC filing?

Sentire Medical Systems, Inc.'s most recent Form D filing was on 2026-02-04.

How many investors does Sentire Medical Systems, Inc. have?

The most recent Form D filing lists 9 investor(s).

Sentire Medical Systems, Inc.

CIK: 0001728443·Biotechnology·PALM BEACH GARDENS, FL

Reported Sold

$1,767,544

Total Filings

Identified Offerings

Last Filed

Feb 4, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Feb 4, 2026Form D — New notice

Reported sold: $1,167,544 · Target: $1,200,000

Rule 506(c)·9 investors

Jan 19, 2018Form D — New notice

Reported sold: $600,000 · Target: $700,000

Rule 506(b)·3 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$1,767,544

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

David Krasne

Executive Officer, Director

Appears on 1 filing

Peng Cheng

Related Person

Appears on 1 filing

David Krasne

Related Person

Appears on 1 filing

Jonathan Diamond

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 4, 2026	New	$1,200,000	$1,167,544	9
Jan 19, 2018	New	$700,000	$600,000	3

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

HCW Biologics Inc.

Biotechnology

Offering target: $1,500,000

Filed Oct 8, 2026